Martin Babler, President, CEO at Principia Biopharma Inc. (PRNB), sold 29,485 shares at $62.38 ($1.8M) on 2020-06-23, disclosed to the SEC on 2020-06-25.
Open-market sale of $1.8M PRNB by President, CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.32 | 515 | $31K | 1.7% |
| 2 | $61.82 | 11,983 | $741K | 40.6% |
| 3 | $61.82 | 11,983 | $741K | 40.6% |
| 4 | $62.38 | 2,502 | $156K | 8.6% |
| 5 | $62.38 | 2,502 | $156K | 8.6% |
| Total | $61.89 avg | 29,485 |
| $1.8M |
| 100% |
| Filing → |
| PRNB | SELL | 2019-12-19 | $2.8M | — | Filing → |